All 1 tracked stories fall under one category: market-trends. Center for Drug Evaluation is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 10 original sources each against 3.3 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Peking Union Medical College Hospital
All 1 tracked stories fall under one category: market-trends. Center for Drug Evaluation is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 10 original sources each against 3.3 for the same window. The 7 average consequence score is above the beat benchmark of 6.6 in the same window. Peking Union Medical College Hospital appears in 1 tracked Healthcare story from March 25, 2026.
Stories tracked
1
Sources per story
10
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Peking Union Medical College Hospital. Shared-story counts are live from our verified record — not editorial picks.
Hope Medicine Inc. has initiated Phase III dosing for HMI-115, the first non-hormonal monoclonal antibody for endometriosis to reach this clinical stage. This milestone, supported by FDA Fast Track and NMPA Breakthrough designations, signals a potential shift away from traditional hormone-suppressing therapies in women's health.
Peking Union Medical College Hospital is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.